Jeff Bluestone’s cell therapy startup Sonoma Biotherapeutics raises another $30M, adds key staff
The South San Francisco company has raised a total of $70 million as it looks to make cell therapies for a range of diseases that include rheumatoid arthritis and amyotrophic lateral sclerosis.